Context-specific emergence and growth of the SARS-CoV-2 Delta variant.
Journal
Nature
ISSN: 1476-4687
Titre abrégé: Nature
Pays: England
ID NLM: 0410462
Informations de publication
Date de publication:
10 2022
10 2022
Historique:
received:
10
12
2021
accepted:
05
08
2022
pubmed:
12
8
2022
medline:
12
10
2022
entrez:
11
8
2022
Statut:
ppublish
Résumé
The SARS-CoV-2 Delta (Pango lineage B.1.617.2) variant of concern spread globally, causing resurgences of COVID-19 worldwide
Identifiants
pubmed: 35952712
doi: 10.1038/s41586-022-05200-3
pii: 10.1038/s41586-022-05200-3
pmc: PMC9534748
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
154-160Subventions
Organisme : NIAID NIH HHS
ID : U19 AI135995
Pays : United States
Organisme : Medical Research Council
ID : MC_PC_19012
Pays : United Kingdom
Organisme : NIAID NIH HHS
ID : R01 AI153044
Pays : United States
Organisme : Medical Research Council
ID : MR/S019510/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_PC_19027
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 204311/Z/16/Z
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 206298/Z/17/Z
Pays : United Kingdom
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Medical Research Council
ID : 220885/Z/20/Z
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 225288/Z/22/Z
Pays : United Kingdom
Organisme : European Research Council
ID : 725422
Pays : International
Organisme : Medical Research Council
ID : MR/W005611/1
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 203783/Z16/Z
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/R015600/1
Pays : United Kingdom
Commentaires et corrections
Type : UpdateOf
Type : UpdateOf
Informations de copyright
© 2022. The Author(s).
Références
Vöhringer, H. S. et al. Genomic reconstruction of the SARS-CoV-2 epidemic in England. Nature 600, 506–511 (2021).
doi: 10.1038/s41586-021-04069-y
Earnest, R. et al. Comparative transmissibility of SARS-CoV-2 variants Delta and Alpha in New England, USA. Cell Rep. Med. 3, 100583 (2022).
doi: 10.1016/j.xcrm.2022.100583
Kupferschmidt, K. & Wadman, M. Delta variant triggers dangerous new phase in the pandemic. Science https://www.sciencemag.org/news/2021/06/delta-variant-triggers-dangerous-new-phase-pandemic (2021).
Vaidyanathan, G. Coronavirus variants are spreading in India—what scientists know so far. Nature 593, 321–322 (2021).
doi: 10.1038/d41586-021-01274-7
Elliott, P. et al. Exponential growth, high prevalence of SARS-CoV-2, and vaccine effectiveness associated with the Delta variant. Science 374, eabl9551 (2021).
doi: 10.1126/science.abl9551
Twohig, K. A. et al. Hospital admission and emergency care attendance risk for SARS-CoV-2 Delta (B.1.617.2) compared with Alpha (B.1.1.7) variants of concern: a cohort study. Lancet Infect. Dis. 22, 35–42 (2021).
doi: 10.1016/S1473-3099(21)00475-8
Lucas, C. et al. Impact of circulating SARS-CoV-2 variants on mRNA vaccine-induced immunity. Nature 600, 523–529 (2021).
doi: 10.1038/s41586-021-04085-y
Challen, R. et al. Early epidemiological signatures of novel SARS-CoV-2 variants: establishment of B.1.617.2 in England. Preprint at bioRxiv https://doi.org/10.1101/2021.06.05.21258365 (2021).
Mishra, S. et al. Changing composition of SARS-CoV-2 lineages and rise of Delta variant in England. eClinicalMedicine 39, 101064 (2021).
doi: 10.1016/j.eclinm.2021.101064
Papa, G. et al. Furin cleavage of SARS-CoV-2 Spike promotes but is not essential for infection and cell–cell fusion. PLoS Pathog. 17, e1009246 (2021).
doi: 10.1371/journal.ppat.1009246
Mlcochova, P. et al. SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion. Nature 599, 114–119 (2021).
doi: 10.1038/s41586-021-03944-y
Cherian, S. et al. SARS-CoV-2 spike mutations, L452R, T478K, E484Q and P681R, in the second wave of COVID-19 in Maharashtra, India. Microorganisms 9, 1542 (2021).
doi: 10.3390/microorganisms9071542
Syed, A. M. et al. Rapid assessment of SARS-CoV-2 evolved variants using virus-like particles. Science 374, 1625–1632 (2021).
doi: 10.1126/science.abl6184
Investigation of SARS-CoV-2 Variants of Concern: Technical Briefings; https://www.gov.uk/government/publications/investigation-of-novel-sars-cov-2-variant-variant-of-concern-20201201 (Public Health England, 2020).
Bericht zu Virusvarianten von SARS-CoV-2 in Deutschland, 9 June 2021; https://www.rki.de/DE/Content/InfAZ/N/Neuartiges_Coronavirus/DESH/Bericht_VOC_2021-06-09 (Robert Koch Institut, 2021).
Abbott, S. & Funk, S. Estimating epidemiological quantities from repeated cross-sectional prevalence measurements. Preprint at medRxiv https://doi.org/10.1101/2022.03.29.22273101 (2022).
Dhar, M. S. et al. Genomic characterization and epidemiology of an emerging SARS-CoV-2 variant in Delhi, India. Science 374, 995–999 (2021).
doi: 10.1126/science.abj9932
du Plessis, L. et al. Establishment and lineage dynamics of the SARS-CoV-2 epidemic in the UK. Science 371, 708–712 (2021).
doi: 10.1126/science.abf2946
Lemey, P. et al. Accommodating individual travel history and unsampled diversity in Bayesian phylogeographic inference of SARS-CoV-2. Nat. Commun. 11, 5110 (2020).
doi: 10.1038/s41467-020-18877-9
SARS-CoV-2 Variants of Concern and Variants Under Investigation in England, Technical briefing 17; https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1001354/Variants_of_Concern_VOC_Technical_Briefing_17.pdf (Public Health England, 2021).
Kraemer, M. U. G. et al. Spatiotemporal invasion dynamics of SARS-CoV-2 lineage B.1.1.7 emergence. Science 373, 889–895 (2021).
doi: 10.1126/science.abj0113
Covid-19: red list arrivals terminal opens at Heathrow Airport. BBC News https://www.bbc.co.uk/news/business-57310148 (2021).
Booking and Staying in a Quarantine Hotel If You’ve Been in a Red List Country https://www.gov.uk/guidance/booking-and-staying-in-a-quarantine-hotel-when-you-arrive-in-england (Department for Transport and Department of Health and Social Care, 2021).
COVID-19 Response—Spring 2021 (Summary); https://www.gov.uk/government/publications/covid-19-response-spring-2021/covid-19-response-spring-2021-summary (UK Cabinet Office, 2021).
Willis, R. Y. A. Coronavirus (COVID-19) Infection Survey, Characteristics of People Testing Positive for COVID-19, UK: 3 November 2021; https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/coronaviruscovid19infectionsurveycharacteristicsofpeopletestingpositiveforcovid19uk/3november2021 (Office for National Statistics, 2021).
Ferguson, N. M. B.1.617.2 Transmission in England: Risk Factors and Transmission Advantage https://www.gov.uk/government/publications/imperial-college-london-delta-b16172-transmission-in-england-risk-factors-and-transmission-advantage-1-june-2021 (Imperial College London, 2021).
Kalkauskas, A. et al. Sampling bias and model choice in continuous phylogeography: Getting lost on a random walk. PLoS Comput. Biol. 17, e1008561 (2021).
doi: 10.1371/journal.pcbi.1008561
Covid: Surge testing in Bedford due to Indian variant. BBC News https://www.bbc.co.uk/news/uk-england-beds-bucks-herts-57151534 (2021).
Jarvis, C. I. et al. CoMix study—Social Contact Survey in the UK; https://cmmid.github.io/topics/covid19/comix-reports.html (2020).
Grenfell, B. T., Bjørnstad, O. N. & Kappey, J. Travelling waves and spatial hierarchies in measles epidemics. Nature 414, 716–723 (2001).
doi: 10.1038/414716a
Lemey, P. et al. Untangling introductions and persistence in COVID-19 resurgence in Europe. Nature 595, 713–717 (2021).
doi: 10.1038/s41586-021-03754-2
Hodcroft, E. B. et al. Spread of a SARS-CoV-2 variant through Europe in the summer of 2020. Nature 595, 707–712 (2021).
doi: 10.1038/s41586-021-03677-y
Volz, E. et al. Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England. Nature 593, 266–269 (2021).
doi: 10.1038/s41586-021-03470-x
Tian, H. et al. An investigation of transmission control measures during the first 50 days of the COVID-19 epidemic in China. Science 368, 638–642 (2020).
doi: 10.1126/science.abb6105
Park, S. W. et al. Roles of generation-interval distributions in shaping relative epidemic strength, speed, and control of new SARS-CoV-2 variants. Preprint at bioRxiv https://doi.org/10.1101/2021.05.03.21256545 (2021).
Kraemer, M. U. G. et al. Monitoring key epidemiological parameters of SARS-CoV-2 transmission. Nat. Med. 27, 1854–1855 (2021).
doi: 10.1038/s41591-021-01545-w
Relatório de Situação Sobre Diversidade Genética do Novo Coronavírus SARS-CoV-2 em Portugal—20-07-2021; http://www.insa.min-saude.pt/relatorio-de-situacao-sobre-diversidade-genetica-do-novo-coronavirus-sars-cov-2-em-portugal-20-07-2021/ (INSA, 2021).
Elliott, P. et al. Twin peaks: the Omicron SARS-CoV-2 BA.1 and BA.2 epidemics in England. Science 376, eabq441 (2022).
doi: 10.1126/science.abq4411
Madhi, S. A. et al. Population immunity and Covid-19 severity with Omicron variant in South Africa. N. Engl. J. Med. 386, 1314–1326 (2022).
doi: 10.1056/NEJMoa2119658
Ali, S. T. et al. Serial interval of SARS-CoV-2 was shortened over time by nonpharmaceutical interventions. Science 369, 1106–1109 (2020).
doi: 10.1126/science.abc9004
Mina, M. J. et al. A Global lmmunological Observatory to meet a time of pandemics. eLife 9, e58989 (2020).
doi: 10.7554/eLife.58989
Bastani, H. et al. Efficient and targeted COVID-19 border testing via reinforcement learning. Nature 599, 108–113 (2021).
doi: 10.1038/s41586-021-04014-z
O’Toole, Á. et al. Assignment of epidemiological lineages in an emerging pandemic using the pangolin tool. Virus Evol. 7, veab064 (2021).
doi: 10.1093/ve/veab064
Minh, B. Q. et al. IQ-TREE 2: new models and efficient methods for phylogenetic inference in the genomic era. Mol. Biol. Evol. 37, 1530–1534 (2020).
doi: 10.1093/molbev/msaa015
Sagulenko, P., Puller, V. & Neher, R. A. TreeTime: maximum-likelihood phylodynamic analysis. Virus Evol. 4, vex042 (2018).
doi: 10.1093/ve/vex042
Suchard, M. A. et al. Bayesian phylogenetic and phylodynamic data integration using BEAST 1.10. Virus Evol. 4, vey016 (2018).
doi: 10.1093/ve/vey016
Hasegawa, M., Kishino, H. & Yano, T. Dating of the human-ape splitting by a molecular clock of mitochondrial DNA. J. Mol. Evol. 22, 160–174 (1985).
doi: 10.1007/BF02101694
Gill, M. S. et al. Improving Bayesian population dynamics inference: a coalescent-based model for multiple loci. Mol. Biol. Evol. 30, 713–724 (2013).
doi: 10.1093/molbev/mss265
Rambaut, A., Drummond, A. J., Xie, D., Baele, G. & Suchard, M. A. Posterior summarization in Bayesian phylogenetics using Tracer 1.7. Syst. Biol. 67, 901–904 (2018).
doi: 10.1093/sysbio/syy032
Price, M. N., Dehal, P. S. & Arkin, A. P. FastTree 2—approximately maximum-likelihood trees for large alignments. PLoS ONE 5, e9490 (2010).
doi: 10.1371/journal.pone.0009490
Zuckerkandl, E. & Pauling, L. B. in Horizons in Biochemistry (eds Kasha, M. & Pullman, B.) 189–225 (Academic Press, 1962).
Pope, A. GB Postcode Area, Sector, District https://doi.org/10.7488/ds/1947 (Univ. of Edinburgh, 2017).
Lemey, P., Rambaut, A., Welch, J. J. & Suchard, M. A. Phylogeography takes a relaxed random walk in continuous space and time. Mol. Biol. Evol. 27, 1877–1885 (2010).
doi: 10.1093/molbev/msq067
SGSS and CHESS Data—NHS Digital; https://digital.nhs.uk/about-nhs-digital/corporate-information-and-documents/directions-and-data-provision-notices/data-provision-notices-dpns/sgss-and-sari-watch-data (NHS, 2021).
Kraemer, M. U. G. et al. Mapping global variation in human mobility. Nat Hum Behav 4, 800–810 (2020).
doi: 10.1038/s41562-020-0875-0
Wilson, R. J. et al. Differentially private SQL with bounded user contribution. Preprint at arXiv https://arxiv.org/abs/1909.01917 (2019).